Inventor · disambiguated record
Edward Walker
Also filed as: WALKER EDWARD · WALKER EDWARD RICHARD
7 granted patents·7 pending applications·4 citations·filing 2008–2023
73Inventor score
Files withBOEHRINGER INGELHEIM INT5TMEM16A LTD4ADORX THERAPEUTICS LTD2ENTPR THERAPEUTICS LTD1HOFFMANN MATTHIAS1
Top patents by PatentIndex Score
14 records- 0180US11364246B2CompoundsTMEM16A LTD·Filed 2019·Granted Jun 21, 2022·2 cites·11 claims
- 0271US8969568B2Substituted naphthyridines and their use as medicamentsHOFFMANN MATTHIAS·Filed 2011·Granted Mar 3, 2015·2 cites·16 claims
- 0365US10947243B2Heteroaryl SYK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 16, 2021·0 cites·2 claims
- 0461US12377105B2CompoundsTMEM16A LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 0559US2024132467A1Benzimidazole derivatives for treating respiratory diseaseTMEM16A LTD·Filed 2023·Application pending·0 cites
- 0658US2025340565A1Cd73 inhibitor compoundsADORX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0753US12415793B2Modulators of TMEM16A for treating respiratory diseaseTMEM16A LTD·Filed 2021·Granted Sep 16, 2025·0 cites·13 claims
- 0853US2023293517A1Antagonist compoundsADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0951US2023203029A1Naphthyridine compounds as inhibitors of mer tyrosine kinase and axl tyrosine kinaseKINSENSUS LTD·Filed 2021·Application pending·0 cites
- 1050US2018072744A1Heteroaryl syk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1150US2010261708A1Diazepane Compounds Which Modulate The CB2 ReceptorBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 1249US9914735B2Heteroaryl Syk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Mar 13, 2018·0 cites·10 claims
- 1343US2020361871A1CompoundsENTPR THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1441US9187478B2Substituted naphthyridines and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Nov 17, 2015·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →